Cardiovascular Disease Clinical Trial
Official title:
The Impact of Age and Fitness on Endothelial Reperfusion Injury and the Ability of Ischemic Preconditioning to Prevent This Injury
Rationale: Ischaemic preconditioning (IP) refers to the reduction of ischemia-reperfusion
injury induced by a brief preceding period of ischemia. Also the arterial endothelium can be
protected by IP. Several studies performed in animals and humans have demonstrated that the
protective effects of IP are attenuated with aging. However, no previous study directly
examined the underlying mechanisms of this observation. Possibly, the reduced protective
effect of IP with aging relates to a direct effect on the endothelium, consequently leading
to an attenuated ability of IP to prevent endothelial dysfunction after ischaemia
reperfusion injury.
Several previous studies failed to demonstrate the ability of pharmacological stimuli to
mimic the beneficial effects of IP in aged vessels. Restoration of the age-related reduction
in effectiveness of IP may be possible through exercise training. In aged animals, physical
training restores the efficacy of ischemic preconditioning. Indirect evidence indicates that
physical activity, independent of other cardiovascular risk factors, protects against a
occurrence as well as the severity of a myocardial infarction in humans. Although this
suggests that physical activity may beneficially influence the age-related reduction in IP,
no previous study provided direct evidence for this hypothesis.
Objective: To examine the impact of age and physical fitness on the ability of ischaemic
preconditioning to protect endothelial damage in response to ischaemia reperfusion injury in
healthy humans. A secondary objective is to explore the role of Toll-like receptor (TLR)
signalling in the induction of IP in young and old subjects.
Status | Completed |
Enrollment | 30 |
Est. completion date | November 2013 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Healthy young volunteers : age 18-30 - Healthy older volunteers: age >55 years - Sedentary: <1 h exercise per week - Trained: >5 h exercise per week - All subjects: written informed consent Exclusion Criteria: - Smoking - History of any cardiovascular disease - Hypertension (in supine position: systole >140 mmHg, diastole >90 mmHg) - Diabetes Mellitus (fasting glucose >7.0 mmol/L or random glucose >11.0 mmol/L) - Hyperlipidaemia (fasting total cholesterol >6.5 mmol/L) - Chronic use of medication known to interfere with the cardiovascular system - Professional athletes - BMI >30 kg/m2 |
Observational Model: Cohort, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Netherlands | Department of Physiology | Nijmegen |
Lead Sponsor | Collaborator |
---|---|
Radboud University |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | endothelial reperfusion injury | Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia) with and without precedence of ischaemic preconditioning (by 3 cycles of 5-minutes of ischaemia). | cross-sectional observation (single time point) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|